226950 — OliX Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for OliX Pharmaceuticals, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	35,540	68,111	49,757	61,872	25,925
Net Total Accounts Receivable
Net Total Receivables	541	518	552	1,147	5,283
Total Inventory
Prepaid Expenses
Total Current Assets	37,440	69,047	52,240	65,046	32,142
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,911	6,180	31,525	37,232	43,910
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	45,207	78,577	86,672	132,651	102,825
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,754	4,488	40,365	39,543	6,563
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,409	33,292	68,151	66,744	52,971
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	41,798	45,286	18,521	65,907	49,855
Total Liabilities & Shareholders' Equity	45,207	78,577	86,672	132,651	102,825
Total Common Shares Outstanding
Total Preferred Shares Outstanding